Update From NIOSH
The National Institute for Occupational Safety and Health (NIOSH) considers a drug to be hazardous if it exhibits one or more of the following characteristics in humans or animals: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or structure and toxicity profiles of new drugs that mimic existing hazardous drugs.
USP General Chapter <800> describes requirements including responsibilities of personnel handling hazardous drugs; facility and engineering controls; procedures for deactivating, decontaminating and cleaning; spill control; and documentation. These standards apply to all healthcare personnel who receive, prepare, administer, transport or otherwise come in contact with hazardous drugs and all the environments in which they are handled.
- USP published the official date of General Chapter <800> of December 1, 2019. The new official date aligns General Chapter <800> with the official date of the new revision of General Chapter <797> Pharmaceutical Compounding — Sterile Preparations, to provide a unified approach to quality compounding.
- May 31, 2019: Revision Bulletin published to confirm the official date of USP General Chapter <800>
- December 1, 2019: Official date for <800>
For more information visit click here.
Read the full update: https://www.usp.org/compounding/general-chapter-hazardous-drugs-handling-healthcare